- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02963415
Concurrent Aerobic Exercise and Virtual Reality Cognitive Training (VRCT)
June 6, 2022 updated by: University of Minnesota
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults
The study will implement and test a unique Virtual Reality Cognitive Training (VRCT) combined with concurrent cycling on a recumbent stationary cycle, also known as exergame that seamlessly integrates specific cognitive tasks into a virtual environment and is synchronized with cycling to promote cognition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed project will implement and test a unique Virtual Reality Cognitive Training (VRCT) combined with concurrent cycling on a recumbent stationary cycle, also known as exergame that seamlessly integrates specific cognitive tasks into a virtual environment and is synchronized with cycling to promote cognition.
Cycling through an interesting virtual environment will motivate and engage the older adult to participate in the exercise, and VRCT could augment cycling's effects on cognition.
The purpose of this project is to demonstrate the feasibility and efficacy of the exergame intervention on cognition through two phases.
In Phase I, a prototype of the VRCT exergame will be developed, followed by a feasibility testing using a single-group mixed methods design.
In Phase II a more fully-featured version of the VRCT exergame will be developed followed by a an RCT which will randomize subjects on a 2:1:1 allocation ratio to 3 parallel groups (exergame:cycling only:attention control).
Mixed methods will be used to assess outcomes in both phases.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 99 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cognitive complaint (defined as answering yes to the question "Do you feel that your memory or thinking skills have gotten worse recently?)
- Not engaging in aerobic exercise or cognitive training >2 days/week, 30 minutes a session in the past 3 months;
- Age 65 years and older
Exclusion Criteria:
- Resting heart rate > 100 or < 50 beats/min;
- Dementia (self-report, diagnosis, or scoring <18 on the modified Telephone Interview for Cognitive Status;
- Neurological or major psychiatric disorder since memory problem;
- Significant diseases, symptoms, or other factors that make exercise unsafe
- Current enrollment in another intervention study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Cognitive Training
Exergame to stimulate cognition
|
Participants will take part in the exergame, 3 times a week for a month.
The session will start for 30-35 minutes of cycling on recumbent stationary cycles in session 1 and progress to moderate intensity for 50 minutes a session.
Participants will do warm-up and cool-down activities before and after cycling.
While cycling, participants will be playing virtual reality based games.
An exercise interventionist will supervise the sessions and monitor participant's conditions and responses to ensure safety.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of the exergame development
Time Frame: Baseline to 3 months
|
development of the exergame prototype by 3 months
|
Baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cycling adherence rate
Time Frame: 3-6 months
|
≥70% subjects adhere to the cycling dose
|
3-6 months
|
|
VCRT adherence rate
Time Frame: 3-6 months
|
≥70% subjects adhere to the cognitive training dose
|
3-6 months
|
|
Usability and satisfaction with the exergame
Time Frame: 3-6 months
|
Participants report acceptable usability and satisfaction with the exergame
|
3-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Fang Yu, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
March 31, 2022
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
November 8, 2016
First Submitted That Met QC Criteria
November 9, 2016
First Posted (Estimate)
November 15, 2016
Study Record Updates
Last Update Posted (Actual)
June 8, 2022
Last Update Submitted That Met QC Criteria
June 6, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1610M98324
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preclinical Alzheimer's Disease
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; Alzheimer's Association; Alzheimer...Active, not recruitingPreclinical Alzheimer's Disease | Early Preclinical Alzheimer's DiseaseUnited States
-
Eisai Inc.National Institute on Aging (NIA); Biogen; Alzheimer's Clinical Trials ConsortiumActive, not recruitingPreclinical Alzheimer's Disease | Early Preclinical Alzheimer's DiseaseUnited States, Canada, Singapore, Japan, Australia, United Kingdom, Spain
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...CompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsCompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Massachusetts General HospitalRecruitingHealthy Aging | Cognitive Decline | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedTerminatedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Gregory Jicha, 323-5550CompletedPreclinical Alzheimer's DiseaseUnited States
-
Nuravax, Inc.National Institute on Aging (NIA); Institute for Molecular MedicineNot yet recruitingAlzheimer Disease | Preclinical Alzheimer's Disease | Alzheimer Disease (AD)United States
-
Paul S. AisenMassachusetts General Hospital; National Institute on Aging (NIA); Alzheimer's... and other collaboratorsNot yet recruitingAlzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
Clinical Trials on Exergame
-
MaineHealthRobert Wood Johnson FoundationCompleted
-
University of California, Los AngelesNational Institute on Aging (NIA); BioSensicsActive, not recruitingCognitive Impairment | Dementia | Mild Cognitive Impairment | Memory LossUnited States
-
Chang Gung UniversityCompleted
-
University of ZurichCompletedVestibular DiseasesSwitzerland
-
Eling DeBruinCompletedMild Neurocognitive DisorderSwitzerland
-
National Yang Ming UniversityUnknown
-
Université de MontréalCompleted
-
University of JaénNot yet recruitingExercise | Pregnant Women | Game
-
Eling DeBruinRecruitingMultiple SclerosisSwitzerland
-
Swiss Federal Institute of TechnologyCompletedEffects of Exergaming on Cognitive Functions in Young AthletenSwitzerland